Journals / Viral Hepatitis Journal / 2016 / Cilt: 22 - Sayı: 3

Gebelikte Ciddi Seyirli Akut Viral Hepatit B: Olgu Sunumu

Acute Viral Hepatitis B with a Severe Clinical Course in Pregnancy: A Case Report

Pages
108–110
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, we present a patient at 16 weeks of pregnancy who was administered tenofovirdisoproxil fumarate due to acute hepatitis B

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The most common cause of non-pregnancy-specific acute hepatitis during pregnancy is hepatitis B.
📊
Key Findings & Data:The clinical course of viral hepatitis B in pregnancy is similar to that in non-pregnant women, and about 1% of patients may develop acute liver failure.
💡
Conclusion & Impact:In this paper, we present a patient at 16 weeks of pregnancy who was administered tenofovirdisoproxil fumarate due to acute hepatitis B
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The most common cause of non-pregnancy-specific acute hepatitis during pregnancy is hepatitis B. The clinical course of viral hepatitis B in pregnancy is similar to that in non-pregnant women, and about 1% of patients may develop acute liver failure. In this paper, we present a patient at 16 weeks of pregnancy who was administered tenofovirdisoproxil fumarate due to acute hepatitis B

Özet

Gebelik esnasında ortaya çıkan ve gebeliğe özgü olmayan en sık akut hepatit nedeni viral hepatit B'dir. Gebelikte viral hepatit B hastalarının klinik seyri gebe olmayanlarla benzer olmasına karşın hastaların yaklaşık %1'i akut karaciğer yetmezliğine ilerleyebilir. Bu yazımızda 16 haftalık gebeliği olan akut hepatit B hastasının takiplerinde ciddi seyirli olması üzerine tenofovir disoproksil fumarat başlanan bir hasta sunulmuştur

🔖

Cite This Article

UYANIKOĞLU, A., AYDIN, F., UYANIKOĞLU, H., YENİCE, N. (2016). Gebelikte Ciddi Seyirli Akut Viral Hepatit B: Olgu Sunumu. Viral Hepatitis Journal, Cilt: 22 - Sayı: 3, 108–110. https://ajindex.com/articles/332838

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Koziel MJ, Siddiqui A. Hepatitis B Virus and Hepatitis Delta Virus. In: Mandell GL, Bennet JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005; p. 1864-1890
  2. Uyanıkoğlu A, Sert U, Çetin B, Uyanıkoğlu H, Yenice N. The Distribution Clinical and Demographic Features of HBsAg Positive Patients in Şanlıurfa Region. Viral Hepat J. 2015;21:89-93
  3. Lee NM, Brady CW. Liver disease in pregnancy. World J Gastroenterol. 2009;15:897-906
  4. Rahman TM, Wendon J. Severe hepatic dysfunction in pregnancy. QJM. 2002;95:343-357
  5. Sookoian S. Liver disease during pregnancy: acute viral hepatitis. Ann Hepatol. 2006;5:231-236
  6. Degertekin B, Lok AS. Indications for therapy in hepatitis B. Hepatology. 2009;49(5 Suppl):129-137
  7. Jaiswal SP, Jain AK, Naik G, Soni N, Chitnis DS. Viral hepatitis during pregnancy. Int J Gynaecol Obstet. 2001;72:103-108
  8. Özdemir S, Akın P. Gebelikte karaciğer hastalıkları. Cerrahpaşa J Med. 2004;35:131-139
  9. Potthoff A, Rifai K, Wedemeyer H, Deterding K, Manns M, Strassburg C. Successful treatment of fulminant hepatitis B during pregnancy. Z Gastroenterol. 2009;47:667-670
  10. Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49(5 Suppl):13-21
  11. Han YT, Sun C, Liu CX, Xie SS, Xiao D, Liu L, Yu JH, Li WW, Li Q. Clinical features and outcome of acute hepatitis B in pregnancy, BMC Infect Dis. 2014;14:368
  12. Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int. 2009;29:133-139
  13. Günşar F. Gebelik ve Hepatit B Virüs Enfeksiyonu. Güncel Gastroenteroloji. 2012;16:299-302
  14. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH; American Association for the Study of Liver Diseases. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63:261
  15. Chen HL, Lee CN, Chang CH, Ni YH, Shyu MK, Chen SM, Hu JJ, Lin HH, Zhao LL, Mu SC, Lai MW, Lee CL, Lin HM, Tsai MS, Hsu JJ, Chen DS, Chan KA, Chang MH; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study); Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV PreMIT Study. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology. 2015;62:375-386
  16. Pan CQ, Duan ZP, Dai EH, Zhang SQ, Rong Han R, Wang Y, Zhang HH, Zou HB, Zhu BS, Zhao WJ, Xiu Jiang H; and the Study Group for the Mother-to-Child Transmission of Hepatitis B i